Status:
UNKNOWN
A Usability Study of External Neuromodulation With iTEAR100 Generation 2
Lead Sponsor:
Olympic Ophthalmics, Inc.
Conditions:
Dry Eye Syndromes
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
A Usability Study of External Neuromodulation With iTEAR100 Generation 2. A study which evaluates user ability to train and access the iTEAR100 device in a telehealth environment.
Detailed Description
A Usability Study of External Neuromodulation With iTEAR100 Generation 2. A study which evaluates user ability to train and access the iTEAR100 device in a telehealth environment. Subjects sign a cons...
Eligibility Criteria
Inclusion
- Able to sign English language consent form and over age 18 and reside in the U.S.
- \-
Exclusion
- \-
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 15 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05304650
Start Date
March 1 2022
End Date
June 15 2022
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Olympic Ophthalmics
Issaquah, Washington, United States, 98027